American Journal of Kidney Diseases
Volume 55, Issue 1 , Pages 50-60 , January 2010

Phase 1 Trial of Adalimumab in Focal Segmental Glomerulosclerosis (FSGS): II. Report of the FONT (Novel Therapies for Resistant FSGS) Study Group

  • Melanie S. Joy, PharmD

      Affiliations

    • UNC Kidney Center and Division of Nephrology and Hypertension, University of North Carolina at Chapel Hill, Chapel Hill, NC
    • School of Pharmacy, Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina at Chapel Hill, Chapel Hill, NC
    • ,
  • Debbie S. Gipson, MD, MSPH

      Affiliations

    • UNC Kidney Center and Division of Nephrology and Hypertension, University of North Carolina at Chapel Hill, Chapel Hill, NC
    • ,
  • Leslie Powell, RN, CPNP

      Affiliations

    • UNC Kidney Center and Division of Nephrology and Hypertension, University of North Carolina at Chapel Hill, Chapel Hill, NC
    • ,
  • Jacqueline MacHardy, BS

      Affiliations

    • UNC Kidney Center and Division of Nephrology and Hypertension, University of North Carolina at Chapel Hill, Chapel Hill, NC
    • ,
  • J. Charles Jennette, MD

      Affiliations

    • Department of Pathology, University of North Carolina at Chapel Hill, Chapel Hill, NC
    • ,
  • Suzanne Vento, RN

      Affiliations

    • Division of Nephrology, Schneider Children's Hospital of North Shore-LIJ Health System, New Hyde Park, NY
    • ,
  • Cynthia Pan, MD

      Affiliations

    • Departments of Pediatrics and Medicine, Division of Nephrology, Medical College of Wisconsin, Milwaukee, WI
    • ,
  • Virginia Savin, MD

      Affiliations

    • Departments of Pediatrics and Medicine, Division of Nephrology, Medical College of Wisconsin, Milwaukee, WI
    • ,
  • Allison Eddy, MD

      Affiliations

    • Division of Nephrology, Seattle Children's Hospital, Seattle, WA
    • ,
  • Agnes B. Fogo, MD

      Affiliations

    • Department of Pathology, Vanderbilt University Medical Center, Nashville, TN
    • ,
  • Jeffrey B. Kopp, MD

      Affiliations

    • Kidney Disease Section, National Institute of Diabetes and Digestive and Kidney Diseases, Kidney Diseases Branch, National Institutes of Health, Bethesda, MD
    • ,
  • Daniel Cattran, MD, FRCPC

      Affiliations

    • Toronto General Research Institute, University Health Network, Toronto, Ontario, Canada
    • ,
  • Howard Trachtman, MD

      Affiliations

    • Division of Nephrology, Schneider Children's Hospital of North Shore-LIJ Health System, New Hyde Park, NY
    • Corresponding Author InformationAddress correspondence to Howard Trachtman, MD, Schneider Children's Hospital, Division of Nephrology, 269-01 76th Ave, New Hyde Park, NY 11040

Received 21 April 2009 ,Accepted 17 August 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Originally published online as doi:10.1053/j.ajkd.2009.08.019 on November 23, 2009.

 Trial registration: www.ClinicalTrials.gov; study number: NCT00814255.

PII: S0272-6386(09)01188-3

doi: 10.1053/j.ajkd.2009.08.019

American Journal of Kidney Diseases
Volume 55, Issue 1 , Pages 50-60 , January 2010

Article Tools

* Image Usage & Resolution